Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
What they're saying: "As the accessibility of these medications continues to rise and patient uptake increases, its crucial that we understand the neural mechanisms underlying the effects were seeing," Lorenzo Leggio, the clinical director of NIHs National Institute on Drug Abuse, said in a statement
This creates sugar cravings and the vicious cycle begins again
GIP/GLP-1s The newest class of drugs that treat both type 2 diabetes and obesity work with both of the main digestive hormones that tell your body to make insulin: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
Understanding how these two agents might work together could inform dietary strategies for patients receiving GLP-1 receptor agonist treatment, though it is important to note that research in this area remains in relatively early stages
Understanding why results vary, and what to do about it, saves patients from unnecessary frustration and premature discontinuation
Understanding what to expect helps you prepare
US$ 21.16
US$ 23.97
US$ 23.36
